Overview

This Solution Provider Webinar is brought to you by DIA in cooperation with

ArisGlobal

The regulatory and pharmacovigilance landscape is evolving substantially with the changing expectations from regulatory authorities. With the increasing number of drugs in the drug development pipeline and a parallel increase in the number of drugs being approved by major regulatory authorities globally, the costs continue to escalate. The pharma model for how clinical and safety data are acquired and managed throughout the lifecycle of a medicinal product needs to evolve and explore ways to decrease costs, increase efficiency, and achieve end-to-end (E-2-E) productivity.

Drug development and pharmacovigilance have traditionally been predominantly human activities, recruiting large numbers of highly-trained and capable staff. Many hours of qualified staff are taken up performing routine and manual activities. Automation, however, has the potential to transform the current drug development and pharmacovigilance processes. With the incorporation of advanced automated technologies, several manual repetitive tasks can be automated. Therefore, highly-trained staff can focus on higher value work, consequently replacing, in some areas, roles that are entirely transactional.

This webinar will:

Detail how organizations can counter the current challenges in regulatory management and pharmacovigilance

Discuss how businesses can become more sophisticated by adopting state-of-the-art cognitive computing processes into their existing systems

Address how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance and regulatory, including productivity, compliance, and data quality

Continuing Education Credits are not available for this event.

Featured topics

Scope of automation in E-2-E regulatory and pharmacovigilance activities

Application of cognitive computing technologies in case-processing, including data entry, medical review, and literature surveillance

How pharmacovigilance systems can help achieve compliance with changing regulations

Understanding the expected productivity gains with the adoption of newer technologies in E-2-E processes

How quality of case-processing can be much better using cognitive computing and robotic process automation

Possibilities and probabilities of automation supporting regulatory transformation

Who should attend?

Professionals who work in the area of:

Pharmacovigilance and Regulatory department business heads, and staff
Staff working on submissions targeting major regulatory authorities
QPPVs, Other business users. IT representatives may get some useful inputs
Medicinal product scope includes - Drugs, Devices, Vaccines and Cosmetics

Learning objectives

At the conclusion of this webinar, participants should be able to:

Describe the role of automation in the day-to-day E-2-E pharmacovigilance to regulatory activities
Evaluate the impact of successful automation in conducting the case-processing tasks
Describe how automated technologies can enable better compliance with the regulations than the traditional systems
Provide evidence of how automation technologies can solve persistence and perennial issues around data quality in systems

Have an account?